Haisigaide Raises New Round Led by Huaxing Kangping for Retinal BCI Vision Restoration
Haisigaide (Suzhou) closed a new financing round led by Huaxing Kangping. The company focuses on blinding eye disease across ultra-micro implants, precision IOP sensing, and retinal BCI vision restoration; proceeds will fund MIGS commercialization and R&D on a retinal fundus-path BCI vision-restoration pipeline.
© 版权声明
The copyright of the article belongs to the author, please do not reprint without permission.